Evaluate Efficacy and Safety of Fingolimod 0.5 mg Orally Once Daily Versus Placebo in Chronic Inflammatory Demyelinating Polyradiculoneuropathy Patients.

Novartis Investigative Site, Brussels

Novartis Investigative Site, Sydney

Novartis Investigative Site, Leuven

Novartis Investigative Site, Parkville

Novartis Investigative Site, Fitzroy

Novartis Investigative Site, Liège

Novartis Investigative Site, Auchenflower

Novartis Investigative Site, Maastricht

Novartis Investigative Site, New York

Novartis Investigative Site, Patchogue

Novartis Investigative Site, Plainview

Novartis Investigative Site, Marseille

Novartis Investigative Site, Legnano

Novartis Investigative Site, Rozzano

Novartis Investigative Site, Madrid

Novartis Investigative Site, Miami

Novartis Investigative Site, Pessac

Novartis Investigative Site, St. Petersburg

Novartis Investigative Site, Montpellier

Novartis Investigative Site, Göttingen

Novartis Investigative Site, Louisville

Novartis Investigative Site, Düsseldorf

Novartis Investigative Site, Columbus

Novartis Investigative Site, Ferrara

Novartis Investigative Site, Bochum

Novartis Investigative Site, Essen

Novartis Investigative Site, Cologne

Novartis Investigative Site, Ramat Gan

Novartis Investigative Site, Pisa

Novartis Investigative Site, Thessaloniki

Novartis Investigative Site, Chicago

Novartis Investigative Site, Tel Aviv

Novartis Investigative Site, Strasbourg

Novartis Investigative Site, Paris

Novartis Investigative Site, Houston

Novartis Investigative Site, Limoges

Novartis Investigative Site, Cefalù

Novartis Investigative Site, Orange

Novartis Investigative Site, Boston

Novartis Investigative Site, Burlington

Novartis Investigative Site, Kingston

Novartis Investigative Site, Québec

Novartis Investigative Site, Greenfield Park

Novartis Investigative Site, Montreal

Novartis Investigative Site, Prague

Novartis Investigative Site, Athens

Novartis Investigative Site, Thessaloniki

Novartis Investigative Site, Haifa

Novartis Investigative Site, Milan

Novartis Investigative Site, Rome

Novartis Investigative Site, Nagoya

Novartis Investigative Site, Aomori

Novartis Investigative Site, Sayama

Novartis Investigative Site, Bunkyo

Novartis Investigative Site, Kodaira

Novartis Investigative Site, Chiba

Novartis Investigative Site, Amsterdam

Novartis Investigative Site, Gdansk

Novartis Investigative Site, Katowice

Novartis Investigative Site, Lodz

Novartis Investigative Site, Barcelona

Novartis Investigative Site, L'Hospitalet de Llobregat

Novartis Investigative Site, Headington

Novartis Investigative Site, Glasgow

Novartis Investigative Site, Liverpool

Novartis Investigative Site, London

Novartis Investigative Site, Newcastle upon Tyne